Skip to main content
Sexual HealthFDA Approved

PT-141

Also known as: Bremelanotide · Vyleesi

PT-141 is a prescription medication or prescription-only peptide topic. Use this page to understand what it is used for, what side effects to ask about, and how it fits into a clinician-guided plan.

Strong Evidence

Robust Phase 3 data supporting approval for HSDD. FDA approval gives it the strongest human evidence base of any sexual health peptide. Off-label male use has supporting clinical data but no formal approval.

Quick take

What to know before you go deeper

What it is

Melanocortin receptor agonist. Unlike PDE5 inhibitors (Viagra), PT-141 acts centrally through the nervous system rather than the vascular system. Works on desire and arousal pathways in the brain.

Approval status

Approval status: FDA Approved. It still requires the right indication, prescription, and follow-up.

Why people ask about it

Low libido in women (FDA-approved), Erectile dysfunction in men (off-label), GLP-1-associated sexual dysfunction.

Ask next

What evidence applies to my situation, what monitoring is needed, and what safer first steps should I try?

Why People Ask About PT-141

  • Low libido in women (FDA-approved)
  • Erectile dysfunction in men (off-label)
  • GLP-1-associated sexual dysfunction
  • Arousal and desire enhancement

Questions to Bring Up

📋

FDA-approved prescription use has label instructions and contraindications. Off-label use should be handled by a licensed clinician.

Dosing, sourcing, and suitability questions belong with a licensed clinician who can review your history, labs, medications, and goals.

Known Side Effects

  • Nausea (most common)
  • Flushing
  • Headache
  • Transient blood pressure increase
  • Injection site reactions

Important Safety Notes

Prescription required for Vyleesi

Do not use with nitrates — risk of hypotension

Blood pressure increase is transient (1–3 hours) but monitor if hypertensive

GLP-1 users report sexual dysfunction as a side effect — PT-141 directly addresses this

What Is Approved?

FDA Approved

FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. Also widely used off-label in men for erectile dysfunction.

Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Peptide therapy should only be undertaken under the supervision of a licensed healthcare provider. Research peptides are not FDA-approved for human use. Full disclaimer →
Was this helpful?

Your feedback helps us improve the guide.